CPG
ACAD icon

Cornerstone Planning Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Cornerstone Planning Group’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-50
Closed -$853 – 1260
2024
Q1 		$853 Buy
+50
New +$853 ﹤0.01% 812